Methotrexate
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „ {{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'P…“) |
|||
| Zeile 2: | Zeile 2: | ||
{{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.|pdf=|usr=008}} | {{tp|p=32534807|t=2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.|pdf=|usr=008}} | ||
{{ttp|p=32471659|t=2020. Silencing of immune activation with methotrexate in patients with COVID-19.|pdf=|usr=008}} | {{ttp|p=32471659|t=2020. Silencing of immune activation with methotrexate in patients with COVID-19.|pdf=|usr=008}} | ||
| + | {{tp|p=32535597|t=2020. Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19.|pdf=|usr=008}} | ||
Version vom 27. Juni 2020, 20:21 Uhr
32534807 2020. Part II. high-dose methotrexate with leucovorin rescue for severe COVID-19: An immune stabilization strategy for SARS-CoV-2 induced 'PANIC' attack.
| 32471659 2020. Silencing of immune activation with methotrexate in patients with COVID-19. |
32535597 2020. Combination of JAKinibs with Methotrexate or Anti-Cytokine Biologics in Patients with Severe COVID-19.
